August 6, 2009 / 1:29 PM / in 8 years

UPDATE 1-Angiotech narrows Q2 loss

* Q2 loss narrows from yr-ago qtr

* Q2 revenue falls 15 pct

(In U.S. dollars)

Aug 6 (Reuters) - Angiotech Pharmaceuticals Inc ANP.TO ANPI.O reported a narrower second-quarter loss on Thursday, helped by lower research costs.

The Vancouver, British Columbia-based company posted a net loss of $11.9 million, or 14 cents a share, compared with a net loss of $26.1 million, or 31 cents a share, a year-ago.

Excluding items, the company posted a net loss of 2 cents a share.

Revenue for the company, which makes coating for Boston Scientific Corp's (BSX.N) stents, fell 15 percent to $64.6 million.

Research and development expenses fell 63 percent to $6.8 million. (Reporting by Anuradha Ramanathan in Bangalore; Editing by Aradhana Aravindan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below